Stay updated on Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new 'Revision: v3.6.6' label appears in the page footer. Several topic-related items ('Lung cancer', 'related topics:', 'MedlinePlus Genetics') and the older 'Revision: v3.6.5' reference were removed.
    Difference
    0.2%
    Check dated 2026-08-29T23:47:10.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    New related topics were added to the study record to improve classification and resource linking, including Lung cancer and MedlinePlus Genetics. These metadata updates help users discover the study under broader disease and genetics-related topics but do not change the trial details or eligibility.
    Difference
    0.2%
    Check dated 2026-08-22T22:31:59.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The deletions remove the 'Lung cancer' keyword, the 'related topics' block, and the 'MedlinePlus Genetics' link from the study page. This reduces the visible disease context and related resource references on the study details page.
    Difference
    0.2%
    Check dated 2026-08-15T23:44:41.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Lung cancer was added as a related topic tag and a related topic link to MedlinePlus Genetics was included. The site revision was updated from v3.6.4 to v3.6.5.
    Difference
    0.2%
    Check dated 2026-08-08T19:10:03.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The site revision tag was updated from v3.6.3 to v3.6.4. This signals a backend/template update without altering the study content or page structure.
    Difference
    0.1%
    Check dated 2026-07-25T10:40:41.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.2 to v3.6.3, indicating a minor update to the page version. This update does not change the displayed study information and is likely a backend tweak or small fix.
    Difference
    0.1%
    Check dated 2026-07-03T21:47:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.